Care Access Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Employee Data

  • Care Access has 670 Employees.(i)
  • Care Access grew their employee count by -26% last year.

Care Access's People

NameTitleEmail/Phone
1
Co-Founder | Community PartnershipsReveal Email/Phone
2
VP, Patient and Physician MarketingReveal Email/Phone
3
Director, Marketing StrategyReveal Email/Phone
4
Associate Director, Clinical DepartmentReveal Email/Phone
5
Senior Marketing ManagerReveal Email/Phone
6
Principal Clinical Trial Project ManagerReveal Email/Phone
7
Manager, Virtual Patient ScreeningReveal Email/Phone
8
Onboarding / Offboarding AnalystReveal Email/Phone
9
Registered Nurse/Clinical Research CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A4752%N/AN/A
#2
N/A3436%N/AN/A
#3
$7.5M64-12%N/AN/A
#4
$3.5M6510%N/AN/A
#5
N/A80%N/AN/A
#6
N/A3025%N/AN/A
#7
$7.5M86121%N/AN/A
#8
$3.5M69-3%N/AN/A
#9
$1.7M1990%N/AN/A
#10
N/A173268%N/AN/A
Add Company

What Is Care Access?

Care Access is a leading decentralized research organization (DRO) that breaks down traditional barriers in clinical research for patients, sponsors, and physicians. Its innovative model brings decentralized trials, Sites On Demand™, Virtual PIs, and Mobile Sites to previously-unreachable patient populations to expand the impact of clinical research. Supported by top pharmaceutical and biotech partners across 20 different therapeutic areas, Care Access is scaling and globalizing its new model for clinical trial delivery, where more physicians and patients can engage in life-saving research to develop new therapies faster. To find out how Care Access is transforming the future of clinical trials, visit www.careaccess.com or email Info@CareAccess.com.

keywords:N/A

N/A

Total Funding

670

Number of Employees

N/A

Revenue (est)

-26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$893.5M6727%N/A
#2
$120M675-7%$1M
#3
$120.2M676103%$55M
#4
$177.7M677-9%N/A
#5
$229.8M6810%N/A